Open AccessSurgical Management of Benign Gastric Tumors: A Review
Author(s) -
Hashem Bark Awadh Abood,
Amani Nasser D. Albalawi,
Haifa Obedullah AlEnazi,
Mousa Mutlaq Almuhanna,
Norah Othman Busaad,
Rafa Ghazi Ali Jarad,
Mahdi Saleh Alkhamis,
Shahad Majed Alsharif,
Mutaz Abdulrahman S. Alahdal,
Deena Ahmed S. Alqahtani,
Abdulmajeed ramzy Alhakamy,
Sulaiman Abdullah Alraqibah
Publication year - 2021
Publication title -
journal of pharmaceutical research international
Language(s) - English
Resource type - Journals
ISSN - 2456-9119
DOI - 10.9734/jpri/2021/v33i60a34502
Subject(s) - medicine , gist , stomach , asymptomatic , endoscopy , radiology , benign tumor , malignant transformation , general surgery , stromal cell , surgery , pathology
Benign stomach and duodenal tumors are uncommon. Any component of the stomach epithelium, whether glandular, endocrine, or mesenchymal, can develop benign neoplastic tumors. The majority of people with benign stomach and duodenal tumors are asymptomatic for a long time. When symptoms do appear, they are determined by the tumor's size, location, and comorbidities. Endoscopy, computed tomography, and especially endoscopic ultrasonography results are used diagnose. Clinically, it's difficult to tell the difference between benign and malignant stomach tumors. Even benign tumors can undergo malignant transformation, severe obstructive problems, and bleeding. As a result, aggressive surgical resection of the tumors should be undertaken. Laparoscopic resection has become the first option of many surgeons since the development of minimally invasive surgery. According to previous literature, laparoscopic excision of GIST is safe and effective. In this review we’ll be looking at benign gastric tumors, gastrointestinal stromal tumors (GISTs) and their diagnosis.